Management of risk factors for accelerated atherosclerosis

[1]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2009, Circulation.

[2]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2009, Circulation.

[3]  W. Hacke,et al.  Results of the Stent-Protected Angioplasty versus Carotid Endarterectomy (SPACE) study to treat symptomatic stenoses at 2 years: a multinational, prospective, randomised trial , 2008, The Lancet Neurology.

[4]  S. Yusuf,et al.  Telmisartan to prevent recurrent stroke and cardiovascular events. , 2008, The New England journal of medicine.

[5]  Vivian Gu,et al.  Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. , 2008, The New England journal of medicine.

[6]  S. Gutnikov,et al.  Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison , 2007, The Lancet.

[7]  F. Podestà,et al.  Underestimate psychological impact of diet intervention. , 2007, Stroke.

[8]  D. Betteridge,et al.  Effects of Pioglitazone in Patients With Type 2 Diabetes With or Without Previous Stroke: Results From PROactive (PROspective pioglitAzone Clinical Trial In macroVascular Events 04) , 2007, Stroke.

[9]  D. Tirschwell.  Aspirin plus dipyridamole was more effective than aspirin alone for preventing vascular events after minor cerebral ischaemia , 2006, Evidence-based medicine.

[10]  C. Schmidt.  Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT) : randomized controlled trial , 2006 .

[11]  M. Hennerici,et al.  High-dose atorvastatin after stroke or transient ischemic attack. , 2006, The New England journal of medicine.

[12]  A. Algra,et al.  Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial , 2006, The Lancet.

[13]  Patrice Cacoub,et al.  Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. , 2006, The New England journal of medicine.

[14]  V. Chair,et al.  Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the , 2006, Circulation.

[15]  W. Benzer,et al.  Is atherosclerosis in diabetes and impaired fasting glucose driven by elevated LDL cholesterol or by decreased HDL cholesterol? , 2005, Diabetes care.

[16]  J. Broderick,et al.  Incidence and Short-Term Prognosis of Transient Ischemic Attack in a Population-Based Study , 2005, Stroke.

[17]  T. Bajwa,et al.  Protected carotid-artery stenting versus endarterectomy in high-risk patients. , 2004, The New England journal of medicine.

[18]  H. Diener,et al.  Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial , 2004, The Lancet.

[19]  R. Peto,et al.  Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial , 2004, The Lancet.

[20]  R. Collins,et al.  Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20 536 people with cerebrovascular disease or other high-risk conditions , 2004, The Lancet.

[21]  D. W. Hawkins,et al.  Atherothrombosis: epidemiology, pathophysiology, and prevention. , 2004, Journal of the American Pharmacists Association : JAPhA.

[22]  P. Rothwell,et al.  Population based study of early risk of stroke after transient ischaemic attack or minor stroke: implications for public education and organisation of services , 2004, BMJ : British Medical Journal.

[23]  J. Leonardi-Bee,et al.  Blood Pressure Reduction and Secondary Prevention of Stroke and Other Vascular Events: A Systematic Review , 2003, Stroke.

[24]  C. Anderson,et al.  Ten-Year Survival After First-Ever Stroke in the Perth Community Stroke Study , 2003, Stroke.

[25]  G. Hankey.  Long-Term Outcome after Ischaemic Stroke/Transient Ischaemic Attack , 2003, Cerebrovascular Diseases.

[26]  M. Reisman,et al.  Carotid Stenting and Endarterectomy: A Clinical and Cost Comparison of Revascularization Strategies , 2002, Stroke.

[27]  A. Mattioli,et al.  Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.

[28]  Catherine Sudlow,et al.  Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.

[29]  M. Woodward,et al.  Randomised trial of a perindopril-based blood pressure lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack , 2001 .

[30]  D. Johnston.  Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack , 2001, The Lancet.

[31]  J M Bland,et al.  Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomised trial , 2001, The Lancet.

[32]  S. Sidney,et al.  Short-term prognosis after emergency department diagnosis of TIA. , 2000, JAMA.

[33]  R. Ross,et al.  Atherosclerosis is an inflammatory disease. , 1998, American heart journal.

[34]  A. Algra,et al.  Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke , 1997, Journal of the Neurological Sciences.

[35]  M. Dennis.  A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee , 1996 .

[36]  H. Diener,et al.  European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke 1 1 ESPS-2 Writing Committee , 1996, Journal of the Neurological Sciences.

[37]  E. Nussbaum,et al.  Cost-effectiveness of carotid endarterectomy. , 1996, Neurosurgery.

[38]  E. Oddone,et al.  Endarterectomy for asymptomatic carotid artery stenosis. , 1995, JAMA.

[39]  Pats-Collaborating-Group-.  Post-stroke antihypertensive treatment study. A preliminary result , 1995 .

[40]  D. Sackett,et al.  Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. , 1991, The New England journal of medicine.

[41]  M. Laakso,et al.  The European Stroke Prevention Study , 1991, Neurology.

[42]  G. Beevers,et al.  Meta-analysis of relation between cigarette smoking and stroke. , 1989, BMJ.

[43]  G. Moneta.  Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20 536 people with cerebrovascular disease or other high-risk conditions Heart , 2022 .

[44]  W. Couldwell,et al.  Review: Yadav JS, Wholey MH, Kuntz RE, et al: Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med 351:1493–1501, 2004 , 2005 .

[45]  D. Clement.  A randomised, blinded, trial of Clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) , 1996 .